BCI Advocates Release Ethical Guidelines for Enhanced Data Control and Device Ownership

Advocates living with brain-computer interfaces (BCIs) have released a set of ethical recommendations aimed at enhancing oversight and control over personal neural data. The document, titled "OUR BCI," was initiated by Ian Burkhart, founder of the BCI Pioneers Coalition, on November 10. This coalition is composed of individuals who use BCIs to manage various disabilities, such as paralysis.

The recommendations cover a range of issues including informed consent, device ownership, and long-term care for those with implanted BCIs. The document outlines specific guidelines that researchers, sponsors, ethics boards, and technology companies must follow to uphold ethical standards throughout the clinical trial process. Notably, these guidelines are designed to evolve every two years, incorporating feedback from additional participants in BCI trials.

Burkhart's journey began after a diving accident in 2010 left him with a C5 spinal cord injury. He became the first person to restore movement to a paralyzed limb using an implanted BCI developed through a collaboration between Battelle and The Ohio State University, utilizing microelectrode arrays from Blackrock Neurotech.

As BCIs approach commercialization globally, there is growing concern about the lack of regulatory frameworks and ethical standards governing their use. This absence has prompted discussions within international bodies like the United Nations and Congress but has yet to result in concrete legislative action.

Ian Burkhart emphasized the importance of involving individuals with disabilities directly in decision-making processes regarding neurotechnology development and regulation. "People with lived experience need meaningful roles," he stated, underscoring the necessity for active participation in shaping policies that affect them.

The recommendations were developed over a year and involved researchers and education specialists from York University and the University of Ottawa. Funding was provided by the Social Sciences and Humanities Research Council of Canada (SSHRC) through a Partnership Engage Grant.

Key among the coalition's recommendations is treating consent as an ongoing dialogue rather than a single agreement, limiting confidentiality agreements that might prevent participants from reporting safety concerns, ensuring fair compensation, and recognizing participants' intellectual contributions. Additionally, they advocate for clearer agreements on hardware and software ownership and provisions for maintenance and support post-trial.

"The foundation we are offering every research team and company running BCI trials is to start with the people who live with the device," Burkhart said. This approach underscores the coalition's commitment to participant autonomy as a cornerstone of ethical research practices.

The coalition includes other prominent members such as Scott Imbrie, Galen Buckwalter, and Robert "Buz" Chmielewski, each contributing unique insights based on their experiences with BCIs. Their collective aim is to establish a binding code of practice that can be enforced globally, ensuring the rights and protections of BCI users are upheld.

In parallel, the United Nations has issued warnings about the potential risks posed by rapidly advancing neurotechnology, particularly concerning individual privacy and freedom of thought. Senior human rights official Claudia Fuentes Julio highlighted these concerns in a report to the General Assembly on October 15, emphasizing the need for clear protections against coercive use by various entities.

"We also need to be precise about what current BCIs can and cannot do," Burkhart noted, clarifying that while BCIs do not read minds in a science fiction sense, they still handle deeply personal data requiring robust protection.